Weekly Intelligence · 5 articles

Vet Industry Intel: Nov 9 – Nov 15, 2025

High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type.

Acquisitions & M&A (1) Regulatory & Policy (4)

Acquisitions & M&A

Nov 9, 2025 [7/10] gnews_practice_acq

Inspire Veterinary Partners Signs Exclusive, Non-Binding Letter of Intent to Acquire New Jersey Animal Hospital - Tallahassee Democrat

Inspire Veterinary Partners has signed an exclusive, non-binding letter of intent to acquire an animal hospital located in New Jersey.

Inspire Veterinary Partners | NJ

Regulatory & Policy

Nov 10, 2025 [8/10] fda_cvm

FDA Completes Safety for Gallant's First Ready-to-Use Stem Cell Therapy for Refractory FCGS - PR Newswire

The FDA has completed safety reviews for Gallant's first ready-to-use stem cell therapy intended for refractory feline chronic gingivostomatitis (FCGS).

FDA · Gallant · PR Newswire

Nov 12, 2025 [8/10] fda_cvm

FDA issues first-ever emergency use authorization for drug to combat screwworm in dogs - American Veterinary Medical Association

The FDA has issued its first-ever emergency use authorization for a drug designed to combat screwworm in dogs.

FDA · American Veterinary Medical Association

Nov 14, 2025 [8/10] doj

Response of United States to Public Comments on the Proposed Final Judgment - Department of Justice (.gov)

The Department of Justice has released its response to public comments regarding a proposed final judgment. This indicates a regulatory process is underway, likely related to antitrust or competition within the veterinary industry.

Department of Justice

Nov 14, 2025 [7/10] fda_cvm

FDA reminds pet food makers that raw ingredients pose risk of exposure to H5N1 - American Veterinary Medical Association

The FDA issued a reminder to pet food manufacturers regarding the risk of H5N1 exposure from raw ingredients.

FDA · American Veterinary Medical Association

Most-mentioned this week

Inspire Veterinary Partners (1)